erythrosine and pyrazolanthrone

erythrosine has been researched along with pyrazolanthrone in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allshire, A; Anoopkumar-Dukie, S; Carey, JB; Conere, T1
Abid, MN; Ahmad, A; Khan, M; Kim, MO; Rehman, SU; Yoon, GH1
Armstead, WM; Cines, DB; Higazi, AA; Kiessling, JW; Riley, J1

Other Studies

3 other study(ies) available for erythrosine and pyrazolanthrone

ArticleYear
Radical mediators and mitogen-activated protein kinase signaling in oxygen-dependent radiosensitivity of human tumor cell lines.
    Free radical biology & medicine, 2005, Jul-15, Volume: 39, Issue:2

    Topics: Acetylcysteine; Anthracenes; Antioxidants; Apoptosis; Ascorbic Acid; Butadienes; Cell Line, Tumor; Cell Proliferation; DNA Damage; Enzyme Inhibitors; Fluoresceins; HeLa Cells; Humans; Imidazoles; MAP Kinase Signaling System; Melatonin; Mitochondria; Nitriles; Nitrites; Oxazines; Oxygen; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Radiation Tolerance; Rhodamines; Spectrometry, Fluorescence; Xanthenes

2005
Inhibition of c-Jun N-Terminal Kinase Protects Against Brain Damage and Improves Learning and Memory After Traumatic Brain Injury in Adult Mice.
    Cerebral cortex (New York, N.Y. : 1991), 2018, 08-01, Volume: 28, Issue:8

    Topics: Amyloid beta-Peptides; Animals; Anthracenes; Blood-Brain Barrier; Brain; Brain Edema; Brain Injuries, Traumatic; Cytokines; Disease Models, Animal; Enzyme Inhibitors; Fluoresceins; JNK Mitogen-Activated Protein Kinases; Learning Disabilities; Maze Learning; Mice; Mice, Inbred C57BL; Peptide Fragments; Psychomotor Performance

2018
Novel plasminogen activator inhibitor-1-derived peptide protects against impairment of cerebrovasodilation after photothrombosis through inhibition of JNK MAPK.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2010, Volume: 299, Issue:2

    Topics: Animals; Animals, Newborn; Anthracenes; Cerebrovascular Circulation; Disease Models, Animal; Erythrosine; Female; Fibrinolytic Agents; Imidazoles; Intracranial Thrombosis; JNK Mitogen-Activated Protein Kinases; Lasers, Solid-State; Male; p38 Mitogen-Activated Protein Kinases; Peptides; Protein Kinase Inhibitors; Pyridines; Recombinant Proteins; Swine; Time Factors; Tissue Plasminogen Activator; Vasoconstriction; Vasodilation

2010